Digging Deep

Defense Metals in the Media

February 16, 2024

Our 2024 Predictions, Part 2

January 11, 2024

Our 2024 Predictions, Part 1

January 02, 2023

Can Gold Hit $3,000 in 2024?

29 December, 2023

Will Bitcoin ETFs Kill Gold?

November 21, 2023

What's Next for Gold?

06 June, 2023

Platinum and Palladium

February 2022

Transition to Production

June 15, 2021

Silver Suppression?!

February 02, 2021

Gold: Year in Review 2020, and 2021 Outlook

January 04, 2021

Gold has big year in 2020 and outlook for this year robust. Learn about monetary expansion and gold future prices.Read More

AbraPlata: CMR's full analysis of an Argentina focussed gold and silver junior

May 2020

The gold futures price reached US$1,767/ounce this week before retreating, which was the second time it has surpassed US$1,760 in the past two months, marking some of gold's highest levels in several years.Read More

GMO Q4 2022 Quarterly Letter.

February 02, 2023 / seekingalpha.com

After a painful 2022, the opportunity set is far better than it was a year ago. Find out why Ben Inker thinks 2022 is a year most investors would like to forget.Read full newsRead More

$SP500 $DJI $SPX - Powell Folds At The River: Meme Stocks Soar, Yields And Dollar Tank.

February 02, 2023 / seekingalpha.com

The Fed raised rates by 0.25% annually this week and indicated further rate increases may be appropriate. Read more on the market reaction with the latest decision.Read full newsRead More

$JNK - JNK: Best Opportunity Vs. U.S. Stocks Since 2008.

February 02, 2023 / seekingalpha.com

SPDR Bloomberg Barclays High Yield Bond ETF offers a significant yield to maturity with much less expected volatility than US stocks. Read why I rate JNK a Buy.Read full newsRead More

$IVAC - Intevac, Inc. 2022 Q4 - Results - Earnings Call Presentation.

February 02, 2023 / seekingalpha.com

The following slide deck was published by Intevac, Inc.Read full newsRead More

$HOLX - Hologic, Inc. (HOLX) Q1 2023 Earnings Call Transcript.

February 02, 2023 / seekingalpha.com

Hologic, Inc. (NASDAQ:NASDAQ:HOLX) Q1 2023 Earnings Conference Call February 1, 2023 4:30 PM ETCompany ParticipantsRyan Simon - VP, IRStephen MacMillan - Chairman, President and CEOKarleen...Read full newsRead More

January AAII Asset Allocation Survey: Equity Exposures Reach 8-Month High.

February 02, 2023 / seekingalpha.com

Stock and stock fund allocations increased by 1.4 percentage points to 65.3%. Bond and bond fund allocations grew slightly, increasing by 0.3 percentage points to 14.6%.Read full newsRead More

$ALGN - Align Technology, Inc. 2022 Q1 - Results - Earnings Call Presentation.

February 02, 2023 / seekingalpha.com

The following slide deck was published by Align Technology, Inc.Read full newsRead More

$SITM - SiTime Corporation (SITM) Q4 2022 Earnings Call Transcript.

February 02, 2023 / seekingalpha.com

SiTime Corporation (NASDAQ:NASDAQ:SITM) Q4 2022 Earnings Conference Call February 1, 2023 5:00 PM ETCompany ParticipantsBrett Perry - Shelton Group Investor RelationsRajesh Vashist - Chief...Read full newsRead More

$BXP - Boston Properties Is Cheap, But Headwinds Are Likely To Persist.

February 02, 2023 / seekingalpha.com

It is not difficult to see that Boston Properties shares are currently quite cheap. Click here to find out why BXP stock is a Hold right now.Read full newsRead More

$GHL - Greenhill & Co, Inc. (GHL) Q4 2022 Earnings Call Transcript.

February 02, 2023 / seekingalpha.com

Greenhill & Co, Inc. (NYSE:NYSE:GHL) Q4 2022 Earnings Conference Call February 1, 2023 4:30 PM ETCompany ParticipantsScott Bok - Chairman & CEOPatrick Suehnholz - Greenhill &...Read full newsRead More

$AVNW - Aviat Networks, Inc. 2023 Q2 - Results - Earnings Call Presentation.

February 02, 2023 / seekingalpha.com

The following slide deck was published by Aviat Networks, Inc.Read full newsRead More

$DIV - DIV: Dividend Yield Unsustainable.

February 02, 2023 / seekingalpha.com

The Global X SuperDividend U.S. ETF offers a dividend yield of 6.4%, which is significantly higher than the S&P 500. Click here to read why I'm neutral on DIV.Read full newsRead More

$AVNW - Aviat Networks, Inc. (AVNW) Q2 2023 Earnings Call Transcript.

February 02, 2023 / seekingalpha.com

Aviat Networks, Inc. (NASDAQ:NASDAQ:AVNW) Q2 2023 Earnings Conference Call February 1, 2023 5:00 PM ETCompany ParticipantsAndrew Fredrickson - Director, Corporate Development & IRPete...Read full newsRead More

$COIN - Coinbase Undervalued And Could Offer Earnings Surprise.

February 02, 2023 / seekingalpha.com

Coinbase is heavily undervalued, and the scope of undervaluation is based on a reversion to strength in FY '24 estimated earnings. See why I'm bullish on COIN.Read full newsRead More

$NTGR - NETGEAR, Inc. (NTGR) Q4 2022 Earnings Call Transcript.

February 02, 2023 / seekingalpha.com

NETGEAR, Inc. (NASDAQ:NASDAQ:NTGR) Q4 2022 Earnings Conference Call February 1, 2023 5:00 PM ETCompany ParticipantsErik Bylin - IRPatrick Lo - Chairman and CEOBryan Murray - CFOConference...Read full newsRead More

$ARLP - Alliance Resource Partners: An Ominous Picture For The Years Ahead.

February 02, 2023 / seekingalpha.com

Alliance Resource Partners posted better-than-expected results for 2022 along with strong guidance for 2023. Click here to read my most recent analysis.Read full newsRead More

$META - Meta Platforms: Still Healing.

February 01, 2023 / seekingalpha.com

Meta Platforms, Inc. reported a surprisingly upbeat Q4 2022 quarter with numbers surging past estimates. Click here for our take on META stock now.Read full newsRead More

$SSNC - SS&C Technologies Produces Flagging Performance.

February 01, 2023 / seekingalpha.com

SS&C Technologies Holdings, Inc. reported its Q3 2022 financial results on October 27, 2022, missing revenue and earnings estimates. Click for our take on SSNC.Read full newsRead More

$IOVA - Iovance: Capturing A Lucrative Market.

February 01, 2023 / seekingalpha.com

Iovance Biotherapeutics, Inc. is poised to complete its rolling Biologic License Application for advanced melanoma this quarter. Click here for our review of IOVA.Read full newsRead More

$VRNA - Verona: Second Successful Phase 3 Moves The Needle Forward.

February 01, 2023 / seekingalpha.com

Verona Pharma's primary endpoint and all key secondary endpoints met in second phase 3 study known as ENHANCE-1. Click here for our updates and review of VRNA.Read full newsRead More

Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok